Skip to main content

Brown-Vialetto-Van Laere Syndrome 2

OMIM ID:

autosomal recessive

Brown-Vialetto-Van Laere Syndrome 2

Alternate Names

BVVLS2

Defective Genes

SLC52A2

Clinical Characteristics

Ocular Features

Decreased vision, optic atrophy, and nystagmus are frequently present.  Pupillary reflexes may be absent.

Systemic Features

Rapidly progressive muscle weakness and ataxia present in childhood.  Early development may be normal but the first symptoms usually appear by age 2 or 3 years of age.  Cognition is usually normal.  Exercise intolerance soon appears along with dysphonia, dyspnea, dysphagia, and weakness of shoulder, neck and axial muscles.  Wasting and weakness of hand muscles is often noticeable.  Kyphoscoliosis, tongue fasciculations, and areflexia are often seen.  Sensorineural hearing loss is a common feature.

Death from respiratory insufficiency often occurs within a few years after onset.

Genetics

Inheritance

Homozygous mutations in the SLC52A2 (8q24.3) gene have been identified in patients with this disorder.

Pedigree

Autosomal recessive

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent.  Carriers with only one mutation, such as the parents, do not have clinical disease.  Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Image
Sample pedigree of autosomal recessive inheritance

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Treatment & Management

Administration of riboflavin has been reported to be beneficial in lessening symptoms.

Selected Resources

Web Resources

Publications

Displaying 1 - 4 of 4

Brown-Vialetto-Van Laere syndrome in a large inbred Lebanese family: Confirmation of autosomal recessive inheritance?

PubMedID: 10797435

Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease

PubMedID: 22740598

SLC52A2 mutations cause SCABD2 phenotype: A second report

PubMedID: 29287867

Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2

PubMedID: 24253200